Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price [Financial Post (Toronto, Ontario, Canada)]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Financial Post
Author of the article: You can save this article by registering for free here . Or sign-in if you have an account. (Bloomberg) — Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S's top executive about lowering the price of its blockbuster drug Ozempic, fueling controversy over the costs of GLP-1 drugs for diabetes and obesity. The Vermont independent said he's considering hearings on the cost of GLP-1 drugs like Ozempic, but first wants to personally discuss their prices with Novo Chief Executive Officer Lars Fruergaard Jørgensen. Article content Article content “We are going to try to make it happen next week,” said Sanders, chair of the Senate Health, Education, Labor and Pensions committee. Ozempic lists in the US for $968.52 for a month's supply of weekly injections. A Novo spokesperson couldn't say whether its CEO would meet with Sanders. In a statement, the company said that “affordability challenges are real” for drugs and that it offers option
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy [Seeking Alpha]Seeking Alpha
- Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024 [Yahoo! Finance]Yahoo! Finance
- Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead [Yahoo! Finance]Yahoo! Finance
- Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Novo Reigns, Stellantis Resilient: EMEA Earnings Week Ahead [BNN Bloomberg (Canada)]BNN Bloomberg
NVO
Earnings
- 11/3/23 - Beat
NVO
Sec Filings
- 4/26/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/25/24 - Form 6-K
- NVO's page on the SEC website